ArticleFrontiers in oncology2025

Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report.

Ranran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.